Myriad Genetics, Inc. (MYGN), a genetic and genomic tumor testing and precision medicine provider, and INTERLINK Care Management, ...

SALT LAKE CITY, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic tumor testing and precision medicine, and INTERLINK Care Management, Inc.

In a comprehensive Genomic Press Interview, Dr. Kerry Ressler, Chief Scientific Officer at McLean Hospital and Professor of Psychiatry at Harvard Medical School, unveils groundbreaking advances in ...

When we can play any part in supporting other families, it’s a tragic gift that allows us to continue to parent Havi.” For families like the Goldstein-Sacks, genetic screening became a pivotal part of ...

Rates of genetic testing for autism and intellectual and development disorders were associated with race, gender, and insurance company.

A patient found to carry a BRCA1 pathogenic variant is not referred to a certified genetic counselor in her health system.

Credit: Courtesy of the researchers; edited by MIT News Every cell in your body contains the same genetic sequence, yet each cell expresses only a subset of those genes. These cell-specific gene ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...

The Purdy family is working with researchers to develop an entirely new clinical trial they hope will save Paxton and other ...

The seventh annual Medical Genetics Awareness Week will be celebrated March 18-21, 2025. The American College of Medical Genetics and Genomics' ...

Jan. 30, 2025 — A research group has developed new advanced light-controlled tools that enable precise control of proteins in real time in living cells. This groundbreaking research opens doors ...